In the course of the trial time period, no less than two deaths involving brain bleeding or hemorrhaging happened among the people taking Lecanemab, so clinicians and caregivers should check clients diligently. Phase III - significant amount of individual teams, intended to verify the security and efficacy on the medicine. https://milofvjxj.blogzet.com/this-article-is-under-review-42492235